“ResApp’s technology is ground-breaking and will greatly enhance the patient journey across a wide range of respiratory diseases, including sleep apnoea,” added Dr Michael Stein. “I am honoured to work with the ResApp team to help improve clinical outcomes through faster and more accurate diagnosis for millions of patients across the world.”
Ann: ResApp Appoints Dr Michael Stein as a Non-Executive Director, page-3
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
